APA (7th ed.) Citation

Ozyerli-Goknar, E., Kala, E. Y., Aksu, A. C., Bulut, I., Cingöz, A., Nizamuddin, S., . . . Bagci-Onder, T. (2023). Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. Cell communication and signaling, 21(1), 1-16. https://doi.org/10.1186/s12964-023-01335-6

Chicago Style (17th ed.) Citation

Ozyerli-Goknar, Ezgi, et al. "Epigenetic-focused CRISPR/Cas9 Screen Identifies (absent, Small, or Homeotic)2-like Protein (ASH2L) as a Regulator of Glioblastoma Cell Survival." Cell Communication and Signaling 21, no. 1 (2023): 1-16. https://doi.org/10.1186/s12964-023-01335-6.

MLA (9th ed.) Citation

Ozyerli-Goknar, Ezgi, et al. "Epigenetic-focused CRISPR/Cas9 Screen Identifies (absent, Small, or Homeotic)2-like Protein (ASH2L) as a Regulator of Glioblastoma Cell Survival." Cell Communication and Signaling, vol. 21, no. 1, 2023, pp. 1-16, https://doi.org/10.1186/s12964-023-01335-6.